<DOC>
	<DOCNO>NCT02812862</DOCNO>
	<brief_summary>The aim study evaluate pulmonary cardiac effect LABA / LAMA combination therapy patient suffer chronic heart failure chronic obstructive pulmonary disease . The secondary aim study assess safety LABA / LAMA combination .</brief_summary>
	<brief_title>Cardiac Effects Fixed-dose Dual Bronchodilator Patients With Heart Insufficiency COPD</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Adults contractually capable mentally able understand follow instruction study personnel Symptomatic regard dyspnea ( NYHA II ) Treatment group : COPD ( FEV1/FVC ratio &lt; 70 % , FEV1 &lt; 80 % ) Control group : No COPD , LAMA LABA Chronic heart failure ( ejection fraction &lt; 40 % ) Stability CHF precede 3 month Male female age &gt; 18 year Written inform consent prior study participation The subject willing able follow procedure outline protocol Lack inform consent Pregnant lactating female Acute exacerbation COPD , acute respiratory failure ( pH &lt; 7,35 and/ respiratory rate &gt; 30/min ) Unstable heart failure plan change medication Not symptomatic Patient commit institution legal regulatory order Participation parallel interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>